BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12817721)

  • 1. Amphetamine induced sensitization in acoustic startle: lack of blockade by adrenalectomy and alpha-helical CRF9-41.
    Chen DY; Liang KC
    Chin J Physiol; 2002 Jun; 45(2):75-87. PubMed ID: 12817721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF).
    Lee Y; Schulkin J; Davis M
    Brain Res; 1994 Dec; 666(1):93-8. PubMed ID: 7889373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex.
    Liang KC; Melia KR; Miserendino MJ; Falls WA; Campeau S; Davis M
    J Neurosci; 1992 Jun; 12(6):2303-12. PubMed ID: 1351540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the acoustic startle reflex by infusion of corticotropin-releasing hormone into the nucleus reticularis pontis caudalis.
    Birnbaum SG; Davis M
    Brain Res; 1998 Jan; 782(1-2):318-23. PubMed ID: 9519280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
    Lee Y; Davis M
    J Neurosci; 1997 Aug; 17(16):6434-46. PubMed ID: 9236251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine.
    Cador M; Cole BJ; Koob GF; Stinus L; Le Moal M
    Brain Res; 1993 Mar; 606(2):181-6. PubMed ID: 8490714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central CRF receptor antagonist a-helical CRF9-41 blocks reinstatement of extinguished fear: the role of the bed nucleus of the stria terminalis.
    Waddell J; Bouton ME; Falls WA
    Behav Neurosci; 2008 Oct; 122(5):1061-9. PubMed ID: 18823163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia.
    Tenn CC; Fletcher PJ; Kapur S
    Schizophr Res; 2003 Nov; 64(2-3):103-14. PubMed ID: 14613675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex.
    Pelton GH; Lee Y; Davis M
    Brain Res; 1997 Dec; 778(2):381-7. PubMed ID: 9459555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
    Russig H; Pryce CR; Feldon J
    Brain Res; 2006 Apr; 1084(1):185-95. PubMed ID: 16563358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
    Swerdlow NR; Britton KT; Koob GF
    Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.
    Brugger S; Sánchez R; Brugger AJ; Martinez JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):775-85. PubMed ID: 9723119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.
    Kumar KB; Karanth KS
    J Neural Transm (Vienna); 1996; 103(8-9):1117-26. PubMed ID: 9013399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
    Broccardo M; Scaccianoce S; Del Bianco P; Agostini S; Petrella C; Improta G
    Neurogastroenterol Motil; 2005 Dec; 17(6):871-7. PubMed ID: 16336503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
    de Jongh R; Groenink L; van der Gugten J; Olivier B
    Biol Psychiatry; 2003 Nov; 54(10):1041-8. PubMed ID: 14625146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypothalamopituitary-adrenal axis and alcohol preference.
    O'Callaghan MJ; Croft AP; Jacquot C; Little HJ
    Brain Res Bull; 2005 Dec; 68(3):171-8. PubMed ID: 16325017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary-adrenal axis responses to acute amphetamine in the rat.
    Swerdlow NR; Koob GF; Cador M; Lorang M; Hauger RL
    Pharmacol Biochem Behav; 1993 Jul; 45(3):629-37. PubMed ID: 8392732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-modified acoustic startle responding and prepulse inhibition in adult and adolescent alcohol-preferring and -nonpreferring rats.
    Bell RL; Rodd ZA; Hsu CC; Lumeng L; Murphy JM; McBride WJ
    Pharmacol Biochem Behav; 2003 Apr; 75(1):163-71. PubMed ID: 12759124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
    Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M
    Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.